EFTF Young Scientist Award for Prof Tobias Kippenberg

Scientists under the age of 40 are honoured with this award sponsored by the Societé Francaise des Microtechniques et de Chronométrie for outstanding advances in the field of time and frequency metrology.

The Prize has been awarded to Professor Kippenberg in May 2011 in San Francisco on the occasion of the International Frequency Control Symposium for his “contributions to optical frequency metrology by the demonstration of monolithic micro resonator frequency comb generators”.

Tobias Kippenberg, born in 1976 in Berlin, studied physics first at the Technichal University Aachen. In 1999 he moved to Caltech (California Institute of Technology, Pasadena, USA), where he received his PhD in 2004. In 2005 he finished his research work at Caltech in the group of Kerry Vahala on the development of microresonators with ultralong photon lifetimes.

He came back to Germany to lead the independent Max Planck Research Group “Laboratory of Photonics and Quantum Measurements” in the Division of Prof. Hänsch. He carried out his habilitation in the area of optomechanics at the chair of Prof. Hänsch at the Ludwig-Maximilians-Universität Munich in 2009. In the same year Tobias Kippenberg was appointed as tenure track assistant professor at the Ecole Polytechnique Fédérale de Lausanne in Switzerland.

The research focus of Professor Kippenberg is on the area of optomechanics using microresonators and their applications in metrology. The “mini-frequency combs” based on monolithic microresonators which have been developed at MPQ can be used for optical frequency measurements and also for designing clocks of extremely high precision. For this development Tobias Kippenberg has already received the renowned Helmholtz Prize of the Physikalisch-Technische Bundesanstalt (PTB) in 2009, together with Dr. Ronald Holtzwarth and Pascal Del`Haye. In the same year Tobias Kippenberg was also awarded the Fresnel Prize for his fundamental contributions to optomechanics.

Contact:

Dr. habil. Tobias J. Kippenberg (PhD)
Ecole Polytechnique Federale de Lausanne (EPFL)
(Swiss Federal Institute of Technology Lausanne)
Associate Professor
Tel: + 41 21 69 34428 (CH) / +41795350016
Dr. Olivia Meyer-Streng
Press and Public Relations
Max Planck Institute of Quantum Optics
Hans-Kopfermann-Str. 1
85748 Garching
olivia.meyer-streng@mpq.mpg.de

Media Contact

Dr. Olivia Meyer-Streng idw

More Information:

http://www.mpq.mpg.de

All latest news from the category: Awards Funding

Back to home

Comments (0)

Write a comment

Newest articles

Distance learning can improve women’s access to vocational training as animal health care practitioners in Nepal. Image Credit: Heifer International

Hybrid Job Training Boosts Women’s Participation in Nepal

Globally, women’s workforce participation is about 25% lower than men’s, often due to barriers such as domestic responsibilities and cultural norms. Vocational training can increase employment opportunities, but women may…

CO2release increase under repeated drying-rewetting cycles (DWCs). Image Credit: Suzuki, Nagano et al., 2025 SOIL

Drying and Rewetting Cycles Boost Soil CO2 Emissions

Niigata, Japan – The amount of carbon dioxide (CO2) released by microbial decomposition of soil organic carbon on a global scale is approximately five times greater than the amount of…

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers. Oregon State's Olena Taratula and collaborators including OSU postdoctoral researcher Babak Mamnoon and Maureen Baldwin, a physician at Oregon Health & Science University, designed a type of drug nanocarrier known as a polymersome to specifically target a protein in choriocarcinoma cells. Depicted is a polymersome with its methotrexate cargo. Illustration by Parinaz Ghanbari. Image Credit: Parinaz Ghanbari

Improved Treatment Method for Rare Pregnancy-Related Cancer

PORTLAND, Ore. – A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other…